166 related articles for article (PubMed ID: 17949236)
1. Down-regulation of vinculin upon MK886-induced apoptosis in LN18 glioblastoma cells.
Magro AM; Magro AD; Cunningham C; Miller MR
Neoplasma; 2007; 54(6):517-26. PubMed ID: 17949236
[TBL] [Abstract][Full Text] [Related]
2. The 5-lipoxygenase-activating protein (FLAP) inhibitor, MK886, induces apoptosis independently of FLAP.
Datta K; Biswal SS; Kehrer JP
Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):371-5. PubMed ID: 10333477
[TBL] [Abstract][Full Text] [Related]
3. A relationship between 5-lipoxygenase-activating protein and bcl-xL expression in murine pro-B lymphocytic FL5.12 cells.
Datta K; Biswal SS; Xu J; Towndrow KM; Feng X; Kehrer JP
J Biol Chem; 1998 Oct; 273(43):28163-9. PubMed ID: 9774436
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886.
Kehrer JP; Biswal SS; La E; Thuillier P; Datta K; Fischer SM; Vanden Heuvel JP
Biochem J; 2001 Jun; 356(Pt 3):899-906. PubMed ID: 11389700
[TBL] [Abstract][Full Text] [Related]
5. Metalloproteinase dependent reduction of cell surface cluster determinants upon the induction of apoptosis.
Magro A; Magro A; Shrestha S; Brundage K; Rankin G
Int J Oncol; 2014 May; 44(5):1539-50. PubMed ID: 24626736
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of the lipocalin 24p3 as an apoptotic mechanism for MK886.
Tong Z; Wu X; Kehrer JP
Biochem J; 2003 May; 372(Pt 1):203-10. PubMed ID: 12614196
[TBL] [Abstract][Full Text] [Related]
7. Fatty acid release and oxidation are factors in lipoxygenase inhibitor-induced apoptosis.
La E; Kern JC; Atarod EB; Kehrer JP
Toxicol Lett; 2003 Mar; 138(3):193-203. PubMed ID: 12565196
[TBL] [Abstract][Full Text] [Related]
8. Roles of 5-lipoxygenase activating protein in cell proliferation and apoptosis.
Wu X; Biswal SS; Kehrer JP
Cell Biol Toxicol; 2003 Jun; 19(3):135-43. PubMed ID: 12945742
[TBL] [Abstract][Full Text] [Related]
9. MK886-induced apoptosis depends on the 5-LO expression level in human malignant glioma cells.
Lim JY; Oh JH; Jung JR; Kim SM; Ryu CH; Kim HT; Jeun SS
J Neurooncol; 2010 May; 97(3):339-46. PubMed ID: 19862483
[TBL] [Abstract][Full Text] [Related]
10. Proteolytic loss of bcl-x(L) in FL5.12 Cells undergoing apoptosis induced by MK886.
Datta K; Kern JC; Biswal SS; Kehrer JP
Toxicol Appl Pharmacol; 2001 Aug; 174(3):273-81. PubMed ID: 11485388
[TBL] [Abstract][Full Text] [Related]
11. Effects of the 5-lipoxygenase activating protein inhibitor MK886 on voltage-gated and Ca2+-activated K+ currents in rat arterial myocytes.
Smirnov SV; Knock GA; Aaronson PI
Br J Pharmacol; 1998 Jun; 124(3):572-8. PubMed ID: 9647483
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of N-acetylcysteine-driven enhancement of MK886-induced apoptosis.
Deshpande VS; Kehrer JP
Cell Biol Toxicol; 2006 Jul; 22(4):303-11. PubMed ID: 16817014
[TBL] [Abstract][Full Text] [Related]
13. Ingenuity network-assisted transcription profiling: Identification of a new pharmacologic mechanism for MK886.
Mayburd AL; Martlínez A; Sackett D; Liu H; Shih J; Tauler J; Avis I; Mulshine JL
Clin Cancer Res; 2006 Mar; 12(6):1820-7. PubMed ID: 16551867
[TBL] [Abstract][Full Text] [Related]
14. 5-Lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate nonnecrotic cell death.
Anderson KM; Seed T; Vos M; Mulshine J; Meng J; Alrefai W; Ou D; Harris JE
Prostate; 1998 Nov; 37(3):161-73. PubMed ID: 9792133
[TBL] [Abstract][Full Text] [Related]
15. Monocytic differentiation of leukemic HL-60 cells induced by co-treatment with TNF-alpha and MK886 requires activation of pro-apoptotic machinery.
Procházková J; Stixová L; Soucek K; Hofmanová J; Kozubík A
Eur J Haematol; 2009 Jul; 83(1):35-47. PubMed ID: 19220423
[TBL] [Abstract][Full Text] [Related]
16. Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.
Woo JS; Kim SM; Jeong CH; Ryu CH; Jeun SS
Biochem Biophys Res Commun; 2013 Feb; 431(2):354-9. PubMed ID: 23261452
[TBL] [Abstract][Full Text] [Related]
17. Combination of all-trans retinoic acid and interferon-gamma upregulated p27(kip1) and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87MG (PTEN-deficient) cells.
Zhang R; Banik NL; Ray SK
Cancer Chemother Pharmacol; 2008 Aug; 62(3):407-16. PubMed ID: 17960384
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition.
Avis I; Martínez A; Tauler J; Zudaire E; Mayburd A; Abu-Ghazaleh R; Ondrey F; Mulshine JL
Cancer Res; 2005 May; 65(10):4181-90. PubMed ID: 15899809
[TBL] [Abstract][Full Text] [Related]
19. Five-lipoxygenase inhibitors reduce Panc-1 survival: the mode of cell death and synergism of MK886 with gamma linolenic acid.
Anderson KM; Seed T; Meng J; Ou D; Alrefai WA; Harris JE
Anticancer Res; 1998; 18(2A):791-800. PubMed ID: 9615721
[TBL] [Abstract][Full Text] [Related]
20. An in vivo inhibitor of 5-lipoxygenase, MK886, at micromolar concentration induces apoptosis in U937 and CML cells.
Anderson KM; Seed T; Jajeh A; Dudeja P; Byun T; Meng J; Ou D; Bonomi P; Harris JE
Anticancer Res; 1996; 16(5A):2589-99. PubMed ID: 8917356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
